Nanotronics Unveils Low-Cost BIPAP Machine to Address Non-Invasive Respiratory Support Needs
June 11, 2020 | Business WireEstimated reading time: 1 minute
Nanotronics announced that it has developed and designed nHale™, a bi-level positive air pressure (BIPAP) device to support spontaneously breathing adults weighing over 30 kg.
The device has obtained Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) to assist patients suffering from COVID-19 disease in traditional healthcare facilities as well as spaces converted for the care of large numbers of COVID-19 patients. It is a noninvasive approach designed to be used in non-life-threatening situations, where a patient is in need of breathing assistance but is not in need of invasive ventilatory support based on standard medical protocols.
In response to Governor Cuomo’s Executive Emergency Order, Nanotronics used their status as an essential company, applying advanced AI, Intelligent Factory Control (IFC), and sophisticated engineering, to create nHale™. During development and testing, Nanotronics consulted with Northwell Hospital emergency medical physicians on the front lines of the most affected area of COVID-19, to ensure the product met the needs of practitioners.
“I was fortunate enough to use a BiPAP machine that provided me with respiratory support after having tested positive for COVID-19,” said Nanotronics CEO and cofounder, Matthew Putman. “Not everyone has that option simply because of accessibility, which to me is unacceptable, and why I feel great about bringing an affordable, human-centered BIPAP device to the people that need it most.”
Nanotronics applied deep in-house expertise to build a machine that is easily manufactured at scale, as well as at reduced cost, to increase accessibility for all Americans. The nHale™ device is designed for comfort and ease-of-use with the simplicity of one button. The machine is for use in hospitals and other healthcare facilities, such as emergency care spaces for COVID-19 patients, prison infirmaries, and nursing care facilities.
National Institute of Health (NIH) COVID-19 treatment guidelines state that noninvasive positive pressure ventilation, such as the nHale™ BIPAP device, is recommended where high-flow nasal cannula oxygen is not available and endotracheal intubation is not indicated.
In addition to distributing the nHale™ to hospitals, Nanotronics will donate a number of machines to healthcare facilities that traditionally serve communities of color and are disproportionally affected by COVID-19. As a partner in START-UP NY with City University of New York, Nanotronics will consult with educational leaders at Medgar Evers College as well as Shaka Senghor, Founder of Redeemed Sole, to determine where nHale™ is most needed within communities of color.
Suggested Items
Ambiq Apollo510 Delivers 30x Power Efficiency Improvement to Unleash Endpoint AI
03/27/2024 | AmbiqAmbiq, a technology leader in exceptionally energy-efficient semiconductors for IoT devices, is introducing the new Apollo510, the first member of the Apollo5 SoC family, which is uniquely positioned to kickstart the age of truly ubiquitous, practical, and meaningful AI.
Commercial Demand Continues to Be the Main Driver of Personal Computing Device Shipments into the GCC Region
03/26/2024 | IDCThe Gulf Cooperation Council (GCC) personal computing device (PCD) market, which is made up of desktops, notebooks, and workstations, declined 4.0% year on year in 2023, with high inventory levels and reduced consumer spending the primary causes.
Absolute EMS Completes ISO 13485:2016 Recertification, Strengthening Commitment to Medical Device Quality Systems
03/25/2024 | Absolute EMS, Inc.Absolute EMS, Inc., an award-winning EMS provider of turnkey contract manufacturing services, proudly announces the successful completion of its ISO 13485:2016 audit, reaffirming its commitment to excellence in medical device manufacturing.
IMAPS Wrap-up: AI, Chiplets, and 3D Cube Architecture
03/22/2024 | Marcy LaRont, PCB007 MagazineThe International Microelectronics Assembly and Packaging Society, IMAPS, held its 20th Device Packaging Expo and Conference this past week in Fountain Hills, Arizona, followed immediately by a ‘Workshop on Advanced Packaging for Medical Electronics’ that continued through the remainder of Thursday. Fortunate to find myself in Texas earlier in the week, I made it for the last day of the IMAPS event and attended two excellent keynote presentations by AMD and Intel, respectively. Here are some highlights.
Global Shipments of Wearables Devices Saw Modest Growth in 2023 with Improved Demand Expected in 2024 and Beyond
03/20/2024 | IDCNew data from the International Data Corporation (IDC) Worldwide Quarterly Wearable Device Tracker shows that the wearable devices market declined 0.9% year over year in the fourth quarter of 2023 (4Q23).